Loading organizations...
§ Private Profile · Stockholm, Stockholms Lan, Sweden
Biotech company developing patent-pending sustainable feed additives for livestock, reducing methane emissions from dairy and beef cattle.
Based in Stockholm, Sweden, Agteria Biotech develops sustainable feed additives designed to significantly reduce enteric methane emissions from dairy cows and beef cattle. The company's patent-pending molecule, known as AB-01, targets agricultural greenhouse gases and can lower livestock methane output by up to 30 percent while remaining nearly one hundred times more affordable than competing red seaweed alternatives. The enterprise recently completed a successful feeding trial involving 120 grazing heifers in the Waikato region of New Zealand, and it aims to achieve commercial product availability for farmers by 2027 pending regulatory approval. To support commercialization and production scaling, the firm has raised approximately €7.4 million in total venture capital funding, backed by notable investors including Industrifonden, Norrsken Launcher, Mudcake, and AgriZeroNZ. Agteria Biotech was founded in 2023 by Martin Blomberg, Tommi Remonen, and Björn Lindh.
Agteria Biotech has raised $8.5M across 2 funding rounds.
Agteria Biotech has raised $8.5M in total across 2 funding rounds.
Agteria Biotech has raised $8.5M across 2 funding rounds. Most recently, it raised $7.0M Seed in February 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 12, 2025 | $7M Seed | Agrizeronz, Industrifonden | — | Announced |
| Mar 27, 2024 | $1.5M Pre Seed | Norrsken VC | — | Announced |
Agteria Biotech has raised $8.5M in total across 2 funding rounds.
Agteria Biotech's investors include AgriZeroNZ, Industrifonden, Norrsken VC.